Serum Institute of India requests US to lift ban on export of raw material required for production of Covishield

Share

Tweet

Share

Share

Email

Comments

Serum Institute of India has requested United States to lift ban on export of raw material required for production of Covishield. In a tweet Serum’s Chief Executive officer Adar Poonawalla tagged US President Joe Biden and requested to lift the embargo on raw material export out of United States. Covishield is the largest used covid vaccine in India. Besides this it is exported to various countries under Vaccine Matri.
 
Serum has signed a $750m agreement with CEPI (Coalition for Epidemic Preparedness Innovations ) and the Vaccine Alliance Gavi to support the manufacturing, procurement and distribution of 300 million doses of the vaccine. In addition, AstraZeneca reached a licensing agreement with SII to supply one billion doses for low and middle-income countries.